Relationship between MLH-1, MSH-2, PMS-2, MSH-6 expression and clinicopathological features in colorectal cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 4, 2015, Pages 4044-4053

  Karahan, Birgül ^a   Argon, Asuman ^a   Yildirim, Mehmet ^a   Vardar, Enver ^a  

^a UNIVERSITY OF HEALTH SCIENCES   (Turkey)

Author keywords

Colorectal cancer; Microsatellite instability; MLH 1; MSH 2; MSH 6; PMS 2

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DNA BINDING PROTEIN; DNA LIGASE; G-T MISMATCH-BINDING PROTEIN; MISMATCH REPAIR PROTEIN PMS2; MLH1 PROTEIN, HUMAN; MSH2 PROTEIN, HUMAN; MUTL PROTEIN HOMOLOG 1; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; PROTEIN MSH2; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; CANCER STAGING; CELL DIFFERENTIATION; CHI SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SECONDARY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR VOLUME; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR ENDONUCLEASE PMS2; MUTL PROTEIN HOMOLOG 1; MUTS HOMOLOG 2 PROTEIN; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84935446794     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-17.
2. Rosai J. Gastrointestinal tract. In: Rosai J, editor. Rosai and Ackerman's Surgical Pathology. China: Elsevier Saunders; 2011. pp. 731-803.
3. Lepisto A, Kiviluoto T, Halttunen J, Jarvinen HJ. Surveillance and treatment of duodenal adenomatosis in familial adenomatous polyposis. Endoscopy 2009; 41: 504-509.
4. Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Colon cancer. Crit Rev Oncol Hematol 2010; 74: 106-33.
5. Kumar V, Robbins and Cotran. Pathologic Basis of Disease. In: Kumar V, Abbas AK, Fausto N, editors. Philadelphia PA: Elsevier Saunders; 2005. pp. 269-342.
6. Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer 2005; 4: 211-218.
7. Bolocan A, Ion D, Ciocan DN, Paduraru DN. Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur) 2012; 107: 555-63.
8. Worthley DL, Whitehall VL, Spring KJ, Leggett BA. Colorectal carsinogenesis: road maps to cancer. World J Gastroenterol 2007; 13: 3784-3791.
9. Umar A, Boland RC, Terdiman JP, Syngal S, de la Chapelle A, Barrett JC, RüschoffJ, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Freedman AN, Srivastava S. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite i{dotless}nstability. J Natl Cancer Inst 2004; 96: 261-268.
10. Whitehall V, Leggett B. Microsatellite instability: detection and management in sporadic colorectal cancer. J Gastroenterol Hepatol 2011; 26: 1697-9.
11. Yoon YS, Yu CS, Kim TW, Kim JH, Jang SJ, Cho DH, Roh SA, Kim JC. Mismatch repair status in sporadic colorectal cancer: immunohistochemistry and microsatellite instability analyses. J Gastroenterol Hepatol 2011; 26: 1733-9.
12. Bosman T, Carneiro F, Hruban RH, Theise ND. World Health Organization Classification of Tumours of the Digestive System. 4th Edition. Lyon, France: IARC Press; 2010. pp. 131-181.
13. Albasri A, Yosef H, Hussainy AS, Sultan SA, Alhujaily A. Histopathological features of colorectal cancer in Al-madinah region of saudi arabia: 8 years experience. Asian Pac J Cancer Prev 2014; 15: 3133-7.
14. Michailidi C, Papavassiliou AG, Troungos C. DNA repair mechanisms in colorectal carcinogenesis. Curr Mol Med 2012; 12: 237-46.
15. Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987; 93: 1021-5.
16. Mark R. Epithelial neoplasms of the large intestine. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract. Liver, Bilier Tract and Pancreas. Elsevier pres; 2004. pp. 441-472.
17. Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous colorectal carcinoma: clinico-pathological features and prognosis. Jpn J Clin Oncol 2003; 33: 38-43.
18. Nitsche U, Zimmermann A, Späth C, Müller T, Maak M, Schuster T, Slotta-Huspenina J, Käser SA, Michalski CW, Janssen KP, Friess H, Rosenberg R, Bader FG. Mucinous and signet-ring ce-ll colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg 2013; 258: 775-783.
19. Leopoldo S, Lorena B, Cinzia A, Gabriella DC, Angela LB, Renato C, Antonio M, Carlo S, Cristina P, Stefano C, Maurizio T, Luigi R, Cesare B. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Ann Surg Oncol 2008; 15: 1429-1439.
20. Greenson JK, Huang SC, Herron C, Moreno V, Bonner JD, Tomsho LP, Ben-Izhak O, Cohen HI, TrougouboffP, Bejhar J, Sova Y, Pinchev M, Rennert G, Gruber SB. Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 2009; 33: 126-33.
21. Sakai E, Takahashi H, Kato S, Uchiyama T, Hosono K, Endo H, Maeda S, Yoneda M, Taguri M, Nakajima A. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm. Cancer Epidemiol Biomarkers Prev 2011; 20: 1918-24.
22. Iacobuzio-Donahue CA. Epithelial Neoplasms of the Colorectum. In: Iacobuzio-Donahue CA, editor. Montgomery EA: Gastrointestinal and Liver Pathology. Pennsylvania: Churchill Livingstone 2005. pp. 367-394.
23. Silverberg SG, De Lellis RA, Frable WJ, Li Volsi VA, Wick MR. Neoplastic diseases of the small and large intestines. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. In: Silverberg SG, editor. Philadelphia: Churchill Livingstone Elsevier; 2006. pp. 1419-1464.
24. Bartley AN, Hamilton SR, Alsabeh R, Ambinder EP, Berman M, Collins E, Fitzgibbons PL, Gress DM, Nowak JA, Samowitz WS, Zafar SY; Members of the Cancer Biomarker Reporting Workgroup, College of American Pathologists. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the colon and rectum. Arch Pathol Lab Med 2014; 138: 166-70.
25. Whitehall V, Leggett B. Microsatellite instability: detection and management in sporadic colorectal cancer. J Gastroenterol Hepatol 2011; 26: 1697-9.
26. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer). N Engl J Med 2005; 352: 1851-1860.
27. Umar A, Boland RC, Terdiman JP, Syngal S, de la Chapelle A, Barrett JC, RüschoffJ, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Freedman AN, Srivastava S. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite i{dotless}nstability. J Natl Cancer Inst 2004; 96: 261-268.
28. Yoon YS, Yu CS, Kim TW, Kim JH, Jang SJ, Cho DH, Roh SA, Kim JC. Mismatch repair status in sporadic colorectal cancer: immunohistoche-mistry and microsatellite instability analyses. J Gastroenterol Hepatol 2011; 26: 1733-9.
29. Chubak B, Heald B, Sharp RR. Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome. Genet Med 2011; 13: 356-60.
30. Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293-300.
31. Shia J, Tang LH, Vakiani E, Guillem JG, Stadler ZK, Soslow RA, Katabi N, Weiser MR, Paty PB, Temple LK, Nash GM, Wong WD, Offit K, Klimstra DS. Immunohistochemistry as first-line scr-eening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol 2009; 33: 1639-45.
32. Amira AT, Mouna T, Ahlem B, Raoudha A, Majid BH, Amel H, Rachida Z, Nadia K. Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability. Tumour Biol 2014; 35: 6283-91.
33. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN. Immunohistochemistry versusmicrosatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-1048.
34. Musulén E, Sanz C, Muñoz-Mármol AM, Ariza A. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome. Hum Pathol 2014; 45: 1388-96.
35. Chapusot C, Martin L, Mungra N, Rageot D, Bo-uvier AM, Bonithon Kopp C, Ponnelle T, Faivre J, Piard F. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relatio-nship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas. Histopathology 2003; 43: 40-7.
36. Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, Resnick MB, TrougouboffP, Tomsho LD, Kim E, Low M, Almog R, Rennert G, Gruber SB. Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003; 27: 563-70.
37. Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N, DranoffG, Giov-annucci EL, Fuchs CS. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15: 6412-20.
38. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, Hawkins N. Microsatellite inst-ability and the clinicopathological features of sporadic colorectal cancer. Gut 2001; 48: 821-9.
39. Redston M. Epithelial Neoplasms of the Large Intestine. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Pennsylvania: Churchill Livingstone 2003. pp. 441-472.
40. Raut CP, Pawlik TM, Rodriguez-Bigas MA. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res 2004; 568: 275-82.
41. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Gro-up: genetic testing strategies in newly diagno-sed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009; 11: 35-41.